Located in Rockville, Maryland, GSK's Human Genome Sciences will be Samsung Biologics' first U.S.-based manufacturing site. | ...

Three Pharma stocks, Panacea Biotec, Sun Pharma, and Strides Pharma, are in the spotlight for notable developments this Friday.

Strides Pharma Science Ltd's Chestnut Ridge facility received four procedural FDA observations, with no impact on supply.

Samsung Biologics America, a subsidiary of Samsing Biologics, a CDMO, has entered into a definitive agreement to acquire 100% ...

TOMI Environmental Solutions, Inc.® ('TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, ...

Bengaluru: Strides Pharma Science has announced that the U.S. Food and Drug Administration (USFDA) has concluded inspection ...

Track key updates on Ola Electric, IndusInd Bank, NTPC, Vodafone Idea, and more in today's must-watch stock list—get the ...

Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced that its wholly owned U.S. subsidiary, Samsung Biologics America, has entered ...

Emcure Pharmaceuticals received a US FDA EIR with No Action Indicated for its Gujarat facility. Shares of Emcure ...

Symbiosis begins commercial manufacturing at new FDA-inspected facilityStirling, Scotland, 22 December 2025 — Symbiosis Pharmaceutical Services (Symbiosis), a leading sterile fill finish contract ...

Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for cell-based solutions through a collaborative network of ...

Samsung Biologics will acquire the Rockville assets for $280 million with closing anticipated toward the end of Q1 of 2026.